21
Participants
Start Date
June 30, 2003
Primary Completion Date
April 30, 2006
Study Completion Date
March 31, 2007
Fabrazyme (agalsidase beta)
1.0 mg/kg Fabrazyme every two weeks for approximately six months followed by 0.3 mg/kg Fabrazyme every two weeks for approximately 18 months
Tartu University Clinics, Department of Internal Medicine, Tartu
II. interní klinika 1. LF UK, Prague
"Klinika Chorob Metabolicznych, Instytut Pomnik-Centrum Zdrowia Dziecka", Warsaw
Detská fakultná nemocnica Kramáre I. Interná klinika, Bratislava
Genzyme, a Sanofi Company
INDUSTRY